CTOR

Citius Oncology
CTOR

7 hedge funds and large institutions have $967K invested in Citius Oncology in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

0.16% more ownership

Funds ownership: 0.15% → 0.31% (+0.16%)

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$465K
2
+$160K
3
+$50.7K
4
Bank of America
Bank of America
North Carolina
+$36.6K

Top Sellers

1
-$149K
2
-$11.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
1
Jane Street
New York
$465K
Geode Capital Management
2
Geode Capital Management
Massachusetts
$249K
IA
3
IFP Advisors
Florida
$96.6K
UBS Group
4
UBS Group
Switzerland
$67.1K
AWA
5
Arkadios Wealth Advisors
Georgia
$50.7K
Bank of America
6
Bank of America
North Carolina
$37.3K
Osaic Holdings
7
Osaic Holdings
Arizona
$402
YCM
8
Yakira Capital Management
Connecticut
–